N/A N=54 Randomized Supportive Care

Transitional Rehabilitation in CABG Patients

Coronary Artery Disease · Coronary Artery Bypass Graft Surgery

Bottom Line

View on ClinicalTrials.gov: NCT03892460 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Aug 2021

Primary outcome: Primary: Short Physical Performance Battery — 7.33; 8.00; 11.44; 10.90 units on a scale

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: neuromuscular electrical stimulation (Device)
Age: Adult, Older Adult · 50+ yrs
Sex: All
Sponsor: University of Vermont
Primary completion: Oct 2019

Outcome Measures

Outcome	Result	p-value
PRIMARY Short Physical Performance Battery	7.33; 8.00; 11.44; 10.90	—
SECONDARY 6 Minute Walk Distance	216; 238; 482; 431	—
SECONDARY Medical Outcomes Short Form 36 - Physical Function	40; 33; 70; 58	—
SECONDARY Medical Outcome Short Form 36 - Role Physical	26; 21; 19; 18	—
SECONDARY Medical Outcomes Short Form 36 - Bodily Pain	31; 28; 28; 27	—
SECONDARY Medical Outcomes Short Form 36 - General Health	71; 63; 81; 72	—
SECONDARY Medical Outcomes Short Form 36 - Vitality	55; 53; 55; 51	—
SECONDARY Medical Outcomes Short Form 36 - Social Function	74; 63; 76; 72	—
SECONDARY Medical Outcomes Short Form 36 - Role Emotional	65; 54; 72; 51	—
SECONDARY Medical Outcomes Short Form 36	77; 74; 86; 78	—
SECONDARY Physical Activity	125.6; 109.6	—

Summary

The goal of this research study is to understand whether an at-home exercise program started soon after CABG surgery, and continuing for 4 weeks following discharge from the hospital, can preserve or improve physical function.

Eligibility Criteria

Inclusion Criteria

50-80 yrs of age
ambulatory
scheduled for coronary artery bypass graft surgery
able to provide informed consent

Exclusion Criteria

rheumatoid arthritis or other inflammatory/autoimmune disease
cancer, excluding non-melanoma skin cancer
exercise limiting peripheral vascular disease
neuromuscular disease or neuromuscular dysfunction associated with cerebrovascular event
body mass index >38 kg/m2
valvular heart disease not corrected surgically
lower extremity blood clot or implantable cardioverter-defibrillator

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03892460). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.